Filing Flows › Comparisons › TKNO vs NTLA
Alpha Teknova vs Intellia Therapeutics: TKNO and NTLA compared
Alpha Teknova is the larger company: $12.7M of revenue in its latest quarter (Q3 2026) against $7.2M for Intellia Therapeutics (Q3 2026). Alpha Teknova is growing faster (+22% against -48% a year earlier).
Where the money goes: TKNO and NTLA
Alpha Teknova (TKNO) · Q3 2026
Alpha Teknova, Q3 2026: revenue $12.7M (+22% year over year), operating margin -25.2%, net loss $3.5M, operating cash flow −$1.3M. The chart follows the revenue to costs, profit and cash.
Intellia Therapeutics (NTLA) · Q3 2026
Intellia Therapeutics, Q3 2026: revenue $7.2M (-48% year over year), net loss $127M, operating cash flow −$85.4M. The chart follows the revenue to costs, profit and cash.
| Alpha Teknova (TKNO) | Intellia Therapeutics (NTLA) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $12.7M | $7.2M |
| Revenue growth, Y/Y | +22% | -48% |
| Operating margin | -25.2% | n/m |
| Net earnings | −$3.5M | −$127M |
| Net margin | -27.5% | — |
| Operating cash flow | −$1.3M | −$85.4M |
Where the revenue comes from
Alpha Teknova
- Lab Essentials: $9.0M (71%)
- Clinical Solutions: $3.2M (25%)
- Other Product: $502K (4%)
Questions
Which is bigger, Alpha Teknova or Intellia Therapeutics?
Alpha Teknova is the larger company: $12.7M of revenue in its latest quarter (Q3 2026) against $7.2M for Intellia Therapeutics (Q3 2026).
Is Alpha Teknova or Intellia Therapeutics growing faster?
Alpha Teknova is growing faster (+22% against -48% a year earlier).
More: Alpha Teknova earnings · how Alpha Teknova makes money · Intellia Therapeutics earnings · how Intellia Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.